Contingency Management to Promote Smoking Abstinence in Cancer Patients

Medical University of South Carolina (MUSC)

Status: Active, not recruiting

Conditions: Smoking Cessation

Treatments: Combination Product: Standard Care; Combination Product: Contingency Management

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT04605458

00099446

R01CA251158-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This is a smoking cessation treatment study. Patients who have a cancer or a suspected cancer who will undergo surgical removal of their cancer are eligible to participate in this study. A novel smoking cessation treatment will be provided to half of the participants in the study. All study participants will receive standard smoking cessation therapy including counseling and the nicotine patch.

Enrollment: 282 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age 18 or older
2. smoking 1 or more combustible tobacco products per day
3. diagnosed with or suspicion of any type of operable cancer

Exclusion criteria

1. unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis, or dementia
2. non-English speaking
3. use of alternative nicotine delivery systems (e.g., e-cigarettes, snus, etc)
4. pregnant women

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

282 participants in 2 patient groups

Contingency Management

Experimental group

Treatment:

Combination Product: Contingency Management

Standard Care

Active Comparator group

Treatment:

Combination Product: Standard Care